Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Song Bai

Showing results (501-510 of 526) with videos related to

Pageof 53
Sort By:
EMBO Molecular Medicine|February 27, 2024
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravisDai-Shi Tian, Chuan Qin, Ming-Hao Dong, et al.
Journal of Visualized Experiments : Jove|March 23, 2026
The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA DamageFang-Tong Liu, Yuan-Hong Huang, Shuai-Shuai Ge, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|February 6, 2008
Coronary angiography with dual source computed tomography: initial experienceZhu-hua Zhang, Zheng-yu Jin, Shu-yang Zhang, et al.
Med (New York, N.Y.)|May 27, 2025
Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathyMing-Hao Dong, Zhi-Cheng Mei, Luo-Qi Zhou, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|January 26, 2007
Retrospective analysis of magnetic resonance myocardial delayed enhancementZhu-Hua Zhang, Qi Miao, Song-Bai Lin, et al.
Cancer Medicine|November 1, 2019
FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cellsJin-Li Li, Jian-Ping Wang, Hong Chang, et al.
Frontiers in Immunology|August 4, 2025
FBXL3 serves as a suppressor of regenerative myogenesisWei He, Shiyuan Han, Yanming Wu, et al.
Signal Transduction and Targeted Therapy|January 3, 2023
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim resultsChuan Qin, Dai-Shi Tian, Luo-Qi Zhou, et al.
Cell|October 16, 2025
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosisChuan Qin, Ming-Hao Dong, Luo-Qi Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 17, 2020
The Clinical and Molecular Characteristics of FLT3 Mutations in Chinese De Novo Adolescent and Adult Acute Lymphoblastic Leukemia PatientsZhen Shen, Xiao-Ling Chu, Rong-Xian Wang, et al.
Pageof 53

Showing results (501-510 of 526) with videos related to

Sort By:
Pageof 53
EMBO Molecular Medicine|February 27, 2024
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravisDai-Shi Tian, Chuan Qin, Ming-Hao Dong, et al.
Journal of Visualized Experiments : Jove|March 23, 2026
The Regimen of Cladribine, Cytarabine, and Venetoclax (CAV) Induces Apoptosis in Acute Myeloid Leukemia Cells by Enhancing DNA DamageFang-Tong Liu, Yuan-Hong Huang, Shuai-Shuai Ge, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|February 6, 2008
Coronary angiography with dual source computed tomography: initial experienceZhu-hua Zhang, Zheng-yu Jin, Shu-yang Zhang, et al.
Med (New York, N.Y.)|May 27, 2025
Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathyMing-Hao Dong, Zhi-Cheng Mei, Luo-Qi Zhou, et al.
Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|January 26, 2007
Retrospective analysis of magnetic resonance myocardial delayed enhancementZhu-Hua Zhang, Qi Miao, Song-Bai Lin, et al.
Cancer Medicine|November 1, 2019
FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cellsJin-Li Li, Jian-Ping Wang, Hong Chang, et al.
Frontiers in Immunology|August 4, 2025
FBXL3 serves as a suppressor of regenerative myogenesisWei He, Shiyuan Han, Yanming Wu, et al.
Signal Transduction and Targeted Therapy|January 3, 2023
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim resultsChuan Qin, Dai-Shi Tian, Luo-Qi Zhou, et al.
Cell|October 16, 2025
Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosisChuan Qin, Ming-Hao Dong, Luo-Qi Zhou, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 17, 2020
The Clinical and Molecular Characteristics of FLT3 Mutations in Chinese De Novo Adolescent and Adult Acute Lymphoblastic Leukemia PatientsZhen Shen, Xiao-Ling Chu, Rong-Xian Wang, et al.
Pageof 53